The phosphoramidite chemistry is unlikely to be replaced by emerging technologies as the demand for primers and short-length DNA sequences are burgeoning within pharmaceuticals, synthetic biology, and molecular diagnostic industries.
BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Phosphoramidite Market – A Global and Regional Analysis.
According to this study, the market size of the global phosphoramidite market was valued at $900.3 million in 2021 and is projected to reach $2.06 billion by 2032.
The following factors are responsible for the increase in demand for phosphoramidite:
The detailed study is a compilation of 06 market data tables and 97 figures spread through 126 pages.
Check out the detailed table of content here:
Analyst’s Take on the Market Projection
According to Sara Virmani, Senior Research Analyst, BIS Research, “Growing research and development activities and demand within the synthetic biology, pharmaceutical, diagnostic, and other industries are increasing the adoption of DNA and RNA-based phosphoramidites. In addition, the increased flow of investments from private and public firms, the emergence of start-ups, and the rising number of partnerships coupled with mergers and acquisitions are fuelling the market growth.”
Request a FREE sample of this report here:
Existing Competitive Landscape
This report is a meticulous compilation of research on more than 17 players in the market ecosystem. It draws upon insights from in-depth interviews with key opinion leaders of leading companies, market participants, and vendors. The report also comprises detailed company profiles, including several key players such as Merck KGaA, Maravai LifeSciences Holdings, Inc, LGC Science Group Holdings Limited, Thermo Fisher Scientific Inc., Qiagen N.V., Danaher Corporation, BOC Sciences, Hongene Biotech Corporation, Creative Biolabs, PolyOrg, Inc., and ChemGenes.
Recent Developments in the Global Phosphoramidites Market
Pharma and Biotech Firms to Hold the Largest Market Share Between 2022-2032
Pharmaceutical and biotechnology companies, diagnostic laboratories and, synthetic biology and research institutes constitute three main entities in the end-user segment for the global phosphoramidite market.
Among these three segments, the pharmaceutical and biotechnology companies segment accounted for the largest share in 2021, holding 47.50% of the market.
This segment is anticipated to retain its position owing to the entry of increased emerging and pipeline novel oligonucleotide-based therapies in the market during the forecast period 2022-2032.
Want to learn more about latest trends in advanced materials and chemicals? Speak to our analysts
Exclusive DeepTech™ MAP Analysis For Healthcare by BIS Research:
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually focusing on several deep technology verticals.
Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscape.
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://bisresearch.com/news
Get Expert Insights @ https://community.insightmonk.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch